22.626 articles found

Parkinson's disease. Bicycle therapy.

Peota C.

Minn Med · 2010-05-01

PMID: 20572560

[Deep brain stimulation--the newest physical method of treatment of depression].

Zyss T, Zieba A, Hese RT, Dudek D, Grabski B.

Psychiatr Pol · 2010-05-01

PMID: 20672511

COMPOSITIONS AND METHODS FOR TREATMENT OF NEURODEGENERATIVE DISEASES

WATSON RICHARD L, WOOD ANTHONY B, ARCHAMBEAU GREGORY J.

· 2010-04-30

PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF PARKINSON'S DISEASE, STRESS, AGING, STROKE OR HUNTINGTON'S DISEASE COMPRISING LOGANIN AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF

JANG CHOON GON.

· 2010-04-30

CLAVULANATE FORMULATION FOR NEUROPROTECTION AND TREATMENT OF NEURODEGENERATIVE DISORDERS

KIM DEOG J, LEE YOUNG B, AHN CHANG H, SCHOLTZ EDWARD C, HUH YOUNGBUHM.

· 2010-04-29

CLAVULANATE FORMULATION FOR NEUROPROTECTION AND TREATMENT OF NEURODEGENERATIVE DISORDERS

KIM DEOG JOONG, LEE YOUNG BOK, AHN CHANG HO, SCHOLTZ EDWARD CARL, HUH YOUNGBUHM.

· 2010-04-29

CLAVULANATE FORMULATION FOR NEUROPROTECTION AND TREATMENT OF NEURODEGENERATIVE DISORDERS

KIM DEOG JOONG, LEE YOUNG BOK, AHN CHANG HO, SCHOLTZ EDWARD CARL, HUH YOUNGBUHM.

· 2010-04-29

Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial.

Williams A, Gill S, Varma T, Jenkinson C, Quinn N, Mitchell R, Scott R, Ives N, Rick C, Daniels J, Patel S, Wheatley K, PD SURG Collaborative Group.

Lancet Neurol · 2010-04-29

DOI: 10.1016/s1474-4422(10)70093-4PMID: 20434403

Pre-treatment with dopamine agonists influence L-dopa mediated rotations without affecting abnormal involuntary movements in the 6-OHDA lesioned rat.

Lane EL, Dunnett SB.

Behav Brain Res · 2010-04-29

DOI: 10.1016/j.bbr.2010.04.034PMID: 20434491

Therapeutic effect of a novel anti-parkinsonian agent zonisamide against MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in mice.

Yokoyama H, Yano R, Kuroiwa H, Tsukada T, Uchida H, Kato H, Kasahara J, Araki T.

Metab Brain Dis · 2010-04-28

DOI: 10.1007/s11011-010-9191-0PMID: 20424905

Intravenous administration of mesenchymal stem cells exerts therapeutic effects on parkinsonian model of rats: focusing on neuroprotective effects of stromal cell-derived factor-1alpha.

Wang F, Yasuhara T, Shingo T, Kameda M, Tajiri N, Yuan WJ, Kondo A, Kadota T, Baba T, Tayra JT, Kikuchi Y, Miyoshi Y, Date I.

BMC Neurosci · 2010-04-26

DOI: 10.1186/1471-2202-11-52PMID: 20420688

[Treatment of mental disorders in patients with Parkinson's disease].

Meincke U, Kosinski CM.

Fortschr Neurol Psychiatr · 2010-04-26

DOI: 10.1055/s-0029-1245307PMID: 20422492